articleThe LancetApr 1, 2011Closed access

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

Duke University Hospital · Duke Medical Center · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,040
total citations
FWCI
67.78
Percentile
100%
References
33
Citations per year

Authors

7

Topics & keywords

Keywords
  • Phentermine
  • Topiramate
  • Medicine
  • Overweight
  • Weight loss
  • Placebo
  • Diabetes mellitus
  • Body mass index
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.